Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
89,32 CHF | -1,40% | -1,94% | +0,70% |
17/01 | Borsa svizzera: chiude in rialzo, SMI +0,40% | AW |
17/01 | Aggiornamento settoriale: i titoli del settore sanitario salgono venerdì prima del mercato | MT |
Gruppo Novartis AG: grafico delle relazioni
Società quotate in Borsa appartenenti allo stesso gruppo: Novartis AG
Società | Capitalizzazione | Manager |
---|---|---|
NOVARTIS INDIA LIMITED | 247 Mln | - |
Scoietà private appartenenti allo stesso gruppo di NOVARTIS AG
Società | Manager |
---|---|
Novartis Healthcare Pvt Ltd.
Novartis Healthcare Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Healthcare Pvt Ltd. is an Indian company that manufactures and markets health care and nutritional products. The company is based in Mumbai, India. The company was founded in 1997. The CEO is Sanjay Prabhakar Murdeshwar. | Sanjay Prabhakar Murdeshwar |
EBEWE Pharma Ges.m.b.H. Nfg.KG
EBEWE Pharma Ges.m.b.H. Nfg.KG Pharmaceuticals: MajorHealth Technology EBEWE Pharma Ges.m.b.H. Nfg.KG engages in the development and manufacture of injectable pharmaceutical specialties. The firm offers therapy solutions for colon, lung, breast, and prostate cancer. It also specializes in drug and pharmaceutical development, as well as preclinical studies. The company was founded in 1934 and is headquartered in Unterach am Attersee, Austria. | - |
Sandoz GmbH
Sandoz GmbH Pharmaceuticals: MajorHealth Technology Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria. | - |
Novartis Pharma GmbH
Novartis Pharma GmbH Pharmaceuticals: MajorHealth Technology Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria. | Shirley Gil Parrado |
Novartis Capital Corp.
Novartis Capital Corp. Finance/Rental/LeasingFinance Novartis Capital Corp. engages in the manufacture of pharmaceutical products. The company is headquartered in East Hanover, NJ. | - |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Vasant Narasimhan |
Novartis Investments SARL
Novartis Investments SARL Financial ConglomeratesFinance Novartis Investments SARL is an investment holding company with interest in medicines and pharmaceuticals sector. The company was founded on July 05, 2002 and is headquartered in Luxembourg. | - |
Novartis BioVentures AG
Novartis BioVentures AG Investment ManagersFinance Part of Novartis AG, Novartis BioVenturesAG is an alternative investment manager. The company is based in Basel, Switzerland. | - |
Novartis Finance SA | - |
Novartis Services, Inc.
Novartis Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Services, Inc. is a healthcare company based in Cambridge, MA. Novartis Services, Inc. aims to deliver these treatments at scale to reach as many patients as possible. Novartis has a longstanding commitment to understanding the molecular basis of disease and is fully committed to good corporate governance. The company's innovative medicines business consists of two separate commercial organizations, Innovative Medicines International and Innovative Medicines US. Additionally, Novartis offers postdoctoral fellowships to train and inspire the next generation of scientific leaders in a unique drug discovery environment. Founded in 2002, Novartis is dedicated to discovering and developing new treatments for diseases such as cancer, heart disease, and neurological conditions. | - |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Novartis International AG manages the Novartis Group. It provides administrative, financial, legal, and technical services. It also offers scientific consultation to the Group. The company was founded on December 13, 1989 and is headquartered in Basel, Switzerland. | Vasant Narasimhan |
Novartis Holding AG
Novartis Holding AG Financial ConglomeratesFinance Part of Novartis AG, Novartis Holding AG is a Swiss healthcare company that provides solutions to address the evolving needs of patients worldwide. The company is based in Basel, Switzerland. Novartis Holding specializes in Managed Access Programs and is committed to the discovery, development, and marketing of innovative products to improve the well-being of all Canadians. The company prides itself on its commitment to diversity and to nurturing an inclusive and inspiring environment. | - |
Novartis Investment Ltd. | - |
MarketScreener is also available in this country: United States.
Switch edition